JP2013500342A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500342A5
JP2013500342A5 JP2012522939A JP2012522939A JP2013500342A5 JP 2013500342 A5 JP2013500342 A5 JP 2013500342A5 JP 2012522939 A JP2012522939 A JP 2012522939A JP 2012522939 A JP2012522939 A JP 2012522939A JP 2013500342 A5 JP2013500342 A5 JP 2013500342A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
aralkyl
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012522939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500342A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043241 external-priority patent/WO2011017054A2/en
Publication of JP2013500342A publication Critical patent/JP2013500342A/ja
Publication of JP2013500342A5 publication Critical patent/JP2013500342A5/ja
Pending legal-status Critical Current

Links

JP2012522939A 2009-07-27 2010-07-26 金属キレート化剤としてのデサザデスフェロチオシンポリエーテルアナログのプロドラッグ Pending JP2013500342A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22869009P 2009-07-27 2009-07-27
US61/228,690 2009-07-27
PCT/US2010/043241 WO2011017054A2 (en) 2009-07-27 2010-07-26 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents

Publications (2)

Publication Number Publication Date
JP2013500342A JP2013500342A (ja) 2013-01-07
JP2013500342A5 true JP2013500342A5 (cg-RX-API-DMAC7.html) 2013-09-12

Family

ID=43544849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012522939A Pending JP2013500342A (ja) 2009-07-27 2010-07-26 金属キレート化剤としてのデサザデスフェロチオシンポリエーテルアナログのプロドラッグ

Country Status (8)

Country Link
US (2) US20110053993A1 (cg-RX-API-DMAC7.html)
EP (1) EP2459544A4 (cg-RX-API-DMAC7.html)
JP (1) JP2013500342A (cg-RX-API-DMAC7.html)
CN (1) CN102648189A (cg-RX-API-DMAC7.html)
AU (1) AU2010281452A1 (cg-RX-API-DMAC7.html)
BR (1) BR112012001761A2 (cg-RX-API-DMAC7.html)
CA (1) CA2768041A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011017054A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003270473A1 (en) 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
MX2007012226A (es) 2005-04-04 2007-12-10 Univ Florida Analogos de polieter de desferritiocina.
EP2137170B1 (en) 2007-03-15 2016-03-09 University of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
MY163516A (en) * 2008-07-14 2017-09-15 Ferrokin Biosciences Inc Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
WO2011140232A2 (en) * 2010-05-04 2011-11-10 Ferrokin Biosciences, Inc Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
ES2571128T3 (es) * 2010-07-26 2016-05-24 Lg Electronics Inc Realimentación aperiódica de información de estado de canal en un sistema de acceso inalámbrico que soporta agregación de múltiples portadoras
EP2787994A4 (en) 2011-12-09 2015-08-26 Ferrokin Biosciences Inc ORAL FORMULATIONS FOR TREATING METAL OVERLOAD
JP6539046B2 (ja) 2011-12-16 2019-07-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. 4’−デスフェリチオシン類似体の使用
TW201427962A (zh) * 2012-12-07 2014-07-16 Ferrokin Biosciences Inc 脫氮雜去鐵硫辛(desazadesferrithiocin)類似物之多晶型形式
US9512095B2 (en) 2013-03-15 2016-12-06 Ferrokin Biosciences, Inc. Polymorph forms of desazadesferrithiocin analogs
CA2930966A1 (en) 2013-11-22 2015-05-28 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
JP2018515475A (ja) 2015-04-27 2018-06-14 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. 代謝的にプログラムされた金属キレーターおよびその使用
EP3575359A4 (en) 2017-01-24 2020-01-01 Sumitomo Rubber Industries, Ltd. TIRES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0214101A3 (de) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
US5840739A (en) * 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
AT500490A1 (de) * 2001-10-16 2006-01-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte
US20060069134A1 (en) * 2002-10-01 2006-03-30 Kaneka Corporation Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
MX2007012226A (es) * 2005-04-04 2007-12-10 Univ Florida Analogos de polieter de desferritiocina.
CA2684837A1 (en) * 2006-12-12 2008-10-30 Raymond J. Bergeron, Jr. Desferrithiocin analogue actinide decorporation agents
EP2137170B1 (en) * 2007-03-15 2016-03-09 University of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
MY163516A (en) * 2008-07-14 2017-09-15 Ferrokin Biosciences Inc Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
US20120184586A1 (en) * 2009-08-25 2012-07-19 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues and uses thereof
WO2011140232A2 (en) * 2010-05-04 2011-11-10 Ferrokin Biosciences, Inc Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents

Similar Documents

Publication Publication Date Title
JP2013500342A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
JP2016521273A5 (cg-RX-API-DMAC7.html)
JP2009502743A5 (cg-RX-API-DMAC7.html)
JP2008520742A5 (cg-RX-API-DMAC7.html)
MY165906A (en) Phenothiazine diaminium salts and their use
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2018504378A5 (cg-RX-API-DMAC7.html)
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
JP2019524883A5 (cg-RX-API-DMAC7.html)
CY1117576T1 (el) Δινουκλεοτιδικα προφαρμακα
TW200608972A (en) Aryl-pyridine derivatives
JP2016519062A5 (cg-RX-API-DMAC7.html)
TW200714583A (en) Substituted gamma lactams as therapeutic agents
UA111770C2 (uk) Інгібітори бромдомену
JP2012533546A5 (cg-RX-API-DMAC7.html)
TW200628154A (en) Organic compounds
EP2620432A3 (en) Diarylhydantoin compounds
JP2012502037A5 (cg-RX-API-DMAC7.html)
SG10201407504YA (en) Pharmaceutical compositions comprising sigma receptor ligands
JP2012510502A5 (cg-RX-API-DMAC7.html)
ES2549503T3 (es) Derivado de 5-hidroxipirimidin-4-carboxamida
MX2012013274A (es) Novedosos derivados de la pirimidina.